Last reviewed · How we verify

NCT06153446

Infection Consortium Study#1

Completed Last updated 27 October 2025
What this trial tests

trial testing Synovasure® Comprehensive Infection Panel in PJI in 810 participants. Completed in 4 September 2025.

Timeline
10 December 2023
Primary endpoint
4 September 2025
4 September 2025

Quick facts

Lead sponsorZimmer Biomet
StatusCompleted
Study typeOBSERVATIONAL
Enrollment810
Start date10 December 2023
Primary completion4 September 2025
Estimated completion4 September 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Zimmer Biomet — full company profile →

Who can join

18 and older, any sex, with PJI. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the Sponsor wants to evaluate the performance and accuracy of the PJI Panel compared to the currently used multiple-criterion scoring systems for the diagnosis of PJI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for PJI

Currently open trials in the same condition.

Other Zimmer Biomet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06153446.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing